EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy

Lin Wang iD, Qingxia Kong, Xinyi Leng, Howan Leung iD, Yang Li

Epilepsia Open · 2025

DOI: 10.1002/epi4.13112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsia Open, 2025. Verfasst von Lin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Affiliated Hospital of Jining Medical University, Jining City, China. Hauptthemen laut MEDLINE: Epilepsy, Sphingosine, Lysophospholipids, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Teachers Research Support Project of Jining Medical University, Key Research and Development Plan Project of Jining City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is one of the common chronic neurological diseases, affecting more than 70 million people worldwide. The brains of people with epilepsy exhibit a pathological and persistent propensity for recurrent seizures. Epilepsy often coexists with cardiovascular disease, cognitive dysfunction, depression, etc., which seriously affects the patient's quality of life. Although our understanding of epilepsy has advanced, the pathophysiological mechanisms leading to epileptogenesis, drug resistance, and associated comorbidities remain largely unknown. The use of newer antiepileptic drugs has increased, but this has not improved overall outcomes. We need to deeply study the pathogenesis of epilepsy and find drugs that can not only prevent the epileptogenesis and interfere with the process of epileptogenesis but also treat epilepsy comorbidities. Sphingosine‐1‐phosphate (S1P) is an important lipid molecule. It not only forms the basis of cell membranes but is also an important bioactive mediator. It can not only act as a second messenger in cells to activate downstream signaling pathways but can also exert biological effects by being secreted outside cells and binding to S1P receptors on the cell membrane. Fingolimod (FTY720) is the first S1P receptor modulator developed and approved for the treatment of multiple sclerosis. More and more studies have proven that the S1P signaling pathway is closely related to epilepsy, drug‐resistant epilepsy, epilepsy comorbidities, or other epilepsy‐causing diseases. However, there is much controversy over the role of certain natural molecules in the pathway and receptor modulators (such as FTY720) in epilepsy. Here, we summarize and analyze the role of the S1P signaling pathway in epilepsy, provide a basis for finding potential therapeutic targets and/or epileptogenic biomarkers, analyze the reasons for these controversies, and put forward our opinions. Plain Language Summary This article combines the latest research literature at home and abroad to review the sphingosine 1‐phosphate signaling pathway and epileptogenesis, drug‐resistant epilepsy, epilepsy comorbidities, other diseases that can cause epilepsy, as well as the sphingosine‐1‐phosphate signaling pathway regulators and epilepsy, with the expectation of providing a certain theoretical basis for finding potential epilepsy treatment targets and/or epileptogenic biomarkers in the sphingosine‐1‐phosphate signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsySphingosineLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Signal TransductionSphingosine-1-Phosphate ReceptorsHumansAnimalsAnticonvulsantsFingolimod HydrochlorideSphingosine Kinase

Stichwörter der Autor:innen

drug‐resistant epilepsyepileptogenesisfingolimodsphingosine‐1‐phosphatesphingosine‐1‐phosphate receptor

Substanzen

SphingosineLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)AnticonvulsantsSphingosine-1-Phosphate ReceptorsFingolimod HydrochlorideSphingosine Kinasesphingosine 1-phosphate

Autor:innen und Institutionen

  • Department of Neurology, Affiliated Hospital of Jining Medical University, Jining City, China.
  • Epilepsy Center, Affiliated Hospital of Jining Medical University, Jining City, China.
  • The Chinese University of Hong Kong, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Central Ave, Hong Kong, Hong Kong.
  • Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, 7/F Clinical Science Building, Prince of Wales Hospital, Hong Kong, Hong Kong.
  • Department of Oncology, Affiliated Hospital of Jining Medical University, Jining City, China.

ORCID-Profile: Lin Wang, Howan Leung

Förderung

  • Teachers Research Support Project of Jining Medical University
  • Key Research and Development Plan Project of Jining City

Zitieren

APA

Wang, L., Kong, Q., Leng, X., Leung, H., & Li, Y. (2025). The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy. Epilepsia Open. https://doi.org/10.1002/epi4.13112

Vancouver

Wang L, Kong Q, Leng X, Leung H, Li Y. The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy. Epilepsia Open. 2025. doi:10.1002/epi4.13112

BibTeX
@article{Wang2025,
  author = {Wang, Lin and Kong, Qingxia and Leng, Xinyi and Leung, Howan and Li, Yang},
  title = {The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.13112}
}
Kostenlos starten →